H1B Report
Side-by-side comparison

COGNIZANT TECHNOLOGY SOLUTIONS US CORP vs Tergus Pharma, LLC

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
TXRank #2FEIN 13-3924155
Entity B
Tergus Pharma, LLC
NCRank #FEIN 45-5123287

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricCOGNIZANT TECHNOLOGY SOLUTIONS US CORPTergus Pharma, LLC
Total filings128,85274
Certified %96.13%86.49%
Denied %0.28%0.00%
Withdrawn %2.23%1.35%
Cert-withdrawn %1.36%12.16%
Rank#2
Active yearsFY2010–FY2026FY2013–FY2026
Worksite stateTXNC

Outcomes — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Cert-withdrawn 1.4%, Withdrawn 2.2%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%

Outcomes — Tergus Pharma, LLC

DOL case-status mix.

Outcome breakdown: Certified 86.5%, Cert-withdrawn 12.2%, Withdrawn 1.4%
Outcome breakdown
OutcomeShare
Certified86.5%
Cert-withdrawn12.2%
Withdrawn1.4%
Certified86.5%
Cert-withdrawn12.2%
Withdrawn1.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

COGNIZANT TECHNOLOGY SOLUTIONS US CORP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,476
FY20112,735
FY20121,772
FY20131,557
FY20142,189
FY20153,112
FY20164,612
FY20172,384
FY201812,460
FY201925,569
FY20203,117
FY202110,079
FY202213,705
FY202315,729
FY202411,437
FY202511,140
FY20265,779
Tergus Pharma, LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20120
FY20134
FY20147
FY20155
FY201611
FY201710
FY201813
FY20192
FY20201
FY20210
FY20220
FY20236
FY20247
FY20255
FY20263

Top 5 occupations — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

Top 5 occupations — Tergus Pharma, LLC

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.